1.34 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 12:45:19 PM)
Exchange closed, opens in 1 day 20 hours
1.52 USD (1.52%)
3.47 USD (3.47%)
19.64 USD (19.64%)
-18.29 USD (-18.29%)
41.20 USD (41.20%)
-93.43 USD (-93.43%)
-99.73 USD (-99.73%)
-99.67 USD (-99.67%)

About Vivani Medical

Market Capitalization 76.41M

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Headquarters (address)

1350 South Loop Road

Alameda 94502 CA

United States

Phone415 506 8462
Websitehttps://www.vivani.com
Employees36
SectorHealthcare
IndustryBiotechnology
TickerVANI
ExchangeNASDAQ Stock Exchange
CurrencyUSD
52 week range0.840 - 7.80
Market Capitalization76.41M
P/E trailing-2.68
P/E forward-2.30
Price/Book3.17
Beta3.52
EPS-0.430
EPS United States (ID:6, base:3399) 24.27

CleverShares.com|
2024 ©

1.0.9092.25789